Cellectis
CLLS
#7481
Rank
โ‚ฌ0.36 B
Marketcap
3,59ย โ‚ฌ
Share price
-2.33%
Change (1 day)
120.45%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚ฌ0.36 Billion

As of January 2026 Cellectis has a market cap of โ‚ฌ0.36 Billion. This makes Cellectis the world's 7481th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.36 B-9.53%
2025โ‚ฌ0.40 B193.47%
2024โ‚ฌ0.13 B-30.69%
2023โ‚ฌ0.19 B118.61%
2022โ‚ฌ91.23 M-73.03%
2021โ‚ฌ0.33 B-67.37%
2020โ‚ฌ1.03 B55.69%
2019โ‚ฌ0.66 B4.07%
2018โ‚ฌ0.63 B-23.84%
2017โ‚ฌ0.84 B45.93%
2016โ‚ฌ0.57 B-41.39%
2015โ‚ฌ0.98 B172.75%
2014โ‚ฌ0.36 B642.67%
2013โ‚ฌ48.48 M

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Cellectis was reported to be:

โ‚ฌ0.26 Billion
by Nasdaq info icon info icon
โ‚ฌ0.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
uniQure
QURE
โ‚ฌ1.17 B 218.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚ฌ1.13 B 210.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ68.04 B 18,439.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ0.39 B 7.75%๐Ÿ‡บ๐Ÿ‡ธ USA